John Sharkey
Corporate Officer/Principal chez GEOVAX LABS, INC.
Fortune : 348 $ au 31/05/2024
Postes actifs de John Sharkey
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GEOVAX LABS, INC. | Corporate Officer/Principal | 13/06/2022 | - |
Historique de carrière de John Sharkey
Anciens postes connus de John Sharkey
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Cogas Consulting LLC | Fondateur | 01/01/2010 | - |
| Largent Health LLC | Directeur Général | - | - |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Shionogi Pharma, Inc.
 Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Corporate Officer/Principal | - | - |
| SUNRIDGE INTERNATIONAL, INC. | Directeur/Membre du Conseil | 05/10/2009 | - |
| Independent Dir/Board Member | 29/09/2009 | - |
Formation de John Sharkey
| State University of New York at Buffalo | Doctorate Degree |
| The State University of New York | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SUNRIDGE INTERNATIONAL, INC. | Health Technology |
| GEOVAX LABS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
| Largent Health LLC | |
| Cogas Consulting LLC |
- Bourse
- Insiders
- John Sharkey
- Expérience
